Table 3 Vectors used for human gene therapy trials
Vector | Number of trials | Percentage of total trials |
|---|---|---|
Adenovirus | 331 | 24.7 |
Retrovirus | 305 | 22.8 |
Vaccinia | 91 | 6.8 |
Poxviruses | 86 | 6.4 |
Adeno-associated virus | 47 | 3.5 |
Herpes simplex virus | 42 | 3.2 |
Nonviral | 343 | 25.6 |
Other | 93 | 7.0 |
Total | 1,338 | 100 |